- Home
- PXLW vs DTIL Comparison
PXLW vs DTIL Comparison
Compare PXLW & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- DTIL
- Stock Information
- Founded
- PXLW 1997
- DTIL 2006
- Country
- PXLW United States
- DTIL United States
- Employees
- PXLW N/A
- DTIL N/A
- Industry
- PXLW Semiconductors
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- PXLW Technology
- DTIL Health Care
- Exchange
- PXLW Nasdaq
- DTIL Nasdaq
- Market Cap
- PXLW 49.1M
- DTIL 43.3M
- IPO Year
- PXLW 2000
- DTIL 2019
- Fundamental
- Price
- PXLW $0.81
- DTIL $5.93
- Analyst Decision
- PXLW Strong Buy
- DTIL Strong Buy
- Analyst Count
- PXLW 3
- DTIL 3
- Target Price
- PXLW $2.17
- DTIL $37.67
- AVG Volume (30 Days)
- PXLW 349.9K
- DTIL 123.5K
- Earning Date
- PXLW 02-12-2025
- DTIL 03-26-2025
- Dividend Yield
- PXLW N/A
- DTIL N/A
- EPS Growth
- PXLW N/A
- DTIL N/A
- EPS
- PXLW N/A
- DTIL 1.45
- Revenue
- PXLW $43,206,000.00
- DTIL $75,096,000.00
- Revenue This Year
- PXLW $10.25
- DTIL $51.35
- Revenue Next Year
- PXLW $39.19
- DTIL N/A
- P/E Ratio
- PXLW N/A
- DTIL $4.07
- Revenue Growth
- PXLW N/A
- DTIL 43.62
- 52 Week Low
- PXLW $0.61
- DTIL $3.61
- 52 Week High
- PXLW $3.08
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- PXLW 46.76
- DTIL 63.88
- Support Level
- PXLW $0.80
- DTIL $4.60
- Resistance Level
- PXLW $0.90
- DTIL $5.23
- Average True Range (ATR)
- PXLW 0.06
- DTIL 0.36
- MACD
- PXLW -0.01
- DTIL 0.13
- Stochastic Oscillator
- PXLW 11.96
- DTIL 88.67
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.